Neogen Chemicals Ltd management interview: Neogen Chemicals Reports Strong Q2 Performance; Revenue Up 42% | CNBC TV18
CNBC-TV18, 2026-11-04. Video: https://www.youtube.com/watch?v=sttBD_ddGKI
- Standalone guidance: Revenue and EBITDA grew almost 40% and almost 50%, respectively. Neogen raised its standalone revenue guidance from 950 to 1,050 crore to 1,050 to 1,150 crore, after completing almost 550 crore.
- Organo-lithium capacity: Production has grown to almost 10 times the level when Neogen acquired the business 3 years ago, and the company has announced plans to double capacity.
- Battery business: Neogen expects 250 to 300 crore in revenue this year, depending on development of the Indian electrolyte business, and at least 1,000 crore next year, backed by an order pipeline and contracts. Salt capacity could be close to 70-80% utilized, supporting PBT positivity next year; electrolyte utilization is expected to remain around 10-20%.
- FY29 outlook: At full utilization, the battery business is projected to generate 2,500 to 2,900 crores of revenue and 500-600 crores of EBITDA, at close to 20% ROCE. Management said working capital days rose to 299 from 264, but it expects to move toward its target of around 180 days by FY27 end as newer plants and lower-cycle businesses ramp up.